MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

GW Pharmaceuticals PLC- Company Profile (NASDAQ:GWPH)

Consensus Ratings for GW Pharmaceuticals PLC- (NASDAQ:GWPH) (?)
Ratings Breakdown: 2 Sell Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $131.25 (43.33% upside)

Analysts' Ratings History for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016Leerink SwannReiterated RatingOutperform$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016Goldman SachsLower Price Target$135.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016Morgan StanleyBoost Price TargetOverweight$149.00 -> $152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2016Piper JaffrayReiterated RatingBuy$147.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Cowen and CompanyReiterated RatingBuy$135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Janney Montgomery ScottInitiated CoverageSell$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Bank of AmericaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Roth CapitalBoost Price TargetBuy$130.00 -> $160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016Numis Securities LtdInitiated CoverageSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2014Peel HuntDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/5/2016Q216($1.57)($0.09)$5.99 million$3.81 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2016Q116($1.53)($0.10)$4.61 million$5.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/7/2015Q415($1.37)($0.85)$15.00 million$5.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q315($1.30)($1.60)$12.82 million$13.55 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q215($1.23)($0.58)$11.38 million$9.43 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2015Q115($1.25)($0.02)$12.12 million$12.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/2/2014Q414($0.69)$0.02$9.15 million$12.03 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q314($1.08)$0.06$12.88 million$13.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.48)($0.04)$12.48 million$12.55 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q413($0.34)($0.02)$11.54 million$7.49 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/19/2013Q4($0.19)($0.29)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2013Q313($0.11)$0.02$10.71 million$11.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($2.35)($1.98)($2.13)
Q2 20163($2.40)($1.44)($2.00)
Q3 20163($2.23)($1.44)($1.89)
Q4 20161($1.62)($1.62)($1.62)
Q1 20171($1.80)($1.80)($1.80)
Q2 20171($1.98)($1.98)($1.98)
Q3 20171($2.34)($2.34)($2.34)
(Data provided by Zacks Investment Research)
Dividend History for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for GW Pharmaceuticals PLC- (NASDAQ:GWPH)
DateHeadline
06/30/16 04:39 PMCompany Target Price Watch: GW Pharmaceuticals Plc (NASDAQ:GWPH) - Telanagana Press
06/29/16 04:18 PMHC Stocks to Path: GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Relypsa Inc (NASDAQ:RLYP) - share market updates (press release)
06/29/16 07:08 AMHealthcare Stocks Need to Be Considers- Medtronic (NYSE:MDT), GW Pharmaceuticals (NASDAQ:GWPH) - Seneca Globe
06/29/16 07:08 AMGW Pharmaceuticals Plc (GWPH) Updated Price Targets - FTSE News
06/28/16 04:17 PMTarget Price Consensus Focus on GW Pharmaceuticals Plc (NASDAQ:GWPH) - Press Telegraph
06/28/16 04:17 PMFocus Stock Recap for: GW Pharmaceuticals Plc (NASDAQ:GWPH) - Telanagana Press
06/28/16 04:17 PMStock in Action: GW Pharmaceuticals plc (NASDAQ:GWPH) - News Oracle
06/28/16 04:17 PMAnalysts Offer Insights on Healthcare Companies: GW Pharmaceuticals plc (NASDAQ: GWPH), Flexion Therapeutics ... - Analyst Ratings
06/28/16 04:17 PMGW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Announces Positive Phase 3 Pivotal Trial Results for Epidiolex ... - Inside Trade
06/28/16 09:51 AMGW Pharmaceuticals PLC- ADR (GWPH): A Beacon of Light in an Otherwise Grim Market - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips GW Pharmaceuticals (GWPH) just sent a bullish message to the market today, turning some lemons into lemonade. The post GW Pharmaceuticals PLC- ADR (GWPH): A Beacon of Light in an Otherwise Grim Market appeared first on InvestorPlace.
06/28/16 09:13 AMMorgan Stanley Sees 70% Upside In GW Pharma
06/28/16 09:13 AMGW Pharma Rallies on Positive Stage 3 Clinical Trial Data
06/28/16 09:13 AMGW Pharma advances on new epilepsy drug trial success
06/28/16 07:45 AMGW Pharmaceuticals (GWPH) Catches Eye: Stock Gains 6.2% -
06/27/16 04:18 PMGW Pharmaceuticals Plc (NASDAQ:GWPH) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 04:18 PMBiotech Beat: GW Pharmaceuticals PLC- ADR (GWPH), Celgene Corporation (CELG) - Smarter Analyst
06/27/16 03:16 PMGW Pharmaceuticals shares soar amid results for epilepsy treatment -
06/27/16 03:11 PMGW Pharma Jumps As Cannabis Drug Treats Severe Epilepsy -
06/27/16 08:46 AMGW Pharma says cannabis-based epilepsy drug meets main goal
06/27/16 08:46 AMGW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
06/27/16 08:41 AMA drug derived from marijuana just cleared another major hurdle toward approval in the US -
06/27/16 08:00 AMInvestors Light Up GW Pharma After Epidiolex Meets Primary Endpoint; Stock Crosses $100 - GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)'s Epidiolex met primary endpoint in the phase three pivotal trial results for the treatment of Lennox-Gastaut Syndrome. The primary endpoint was achieved with superior statistical significance demonstrating that Epidiolex treatment reduces drop seizures compared to the placebo. In the pre-market on Monday, the stock traded up 20 percent at $100. GW Pharmaceuticals said that the study followed the disclosure in March last about positive results in a pivotal Phase 3 study of Epidiolex for the treatment of Dravet syndrome. The company pointed out that its Epidiolex has Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for LGS and Dravet syndrome ...Full story available on Benzinga.com
06/25/16 04:05 PMGW Pharmaceuticals Plc (NASDAQ:GWPH): Update on Stock Performance - Press Telegraph
06/24/16 11:14 AMHow Many GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH)'s Analysts Are Bullish? - Press Telegraph
06/24/16 11:14 AMImpact Score Outlook on:GW Pharmaceuticals Plc (NASDAQ:GWPH) - Press Telegraph
06/24/16 11:14 AMConsensus View on GW Pharmaceuticals Plc (NASDAQ:GWPH) Stock and Check on Movement - Press Telegraph
06/23/16 09:33 PMChecking in on Consensus Views for GW Pharmaceuticals Plc (NASDAQ:GWPH) - Press Telegraph
06/23/16 03:34 PMGW Pharmaceuticals : selects infantile spasms for Epidiolex development program
06/23/16 07:16 AMRecently Issued Stock Ratings For GW Pharmaceuticals Plc (GWPH) - Fiscal Standard
06/23/16 07:16 AMStock Update (NASDAQ:GWPH): GW Pharmaceuticals PLC- ADR Announces New Planned Epidiolex Development ... - Smarter Analyst
06/23/16 07:16 AMGW Pharmaceuticals PLC-ADR: Why GWPH Is Set to Burn Higher - Investorplace.com
06/22/16 11:32 AMGW Pharmaceuticals PLC-ADR: Why GWPH Is Set to Burn Higher - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips After a positive phase-III trial for GW Pharmaceuticals, with more trials underway, GWPH stock is looking better and better. The post GW Pharmaceuticals PLC-ADR: Why GWPH Is Set to Burn Higher appeared first on InvestorPlace.
06/22/16 09:01 AMGW Pharma (GWPH) to Develop Epidiolex for Infantile Spasms
06/22/16 09:01 AMGW Pharmaceuticals Selects Infantile Spasms for CBD Drug Indication
06/21/16 04:06 PMGW Pharmaceuticals : Infantile spasms selected as 4th target indication for Epidiolex
06/21/16 04:06 PMGW Pharmaceuticals Targets Infantile Spasms For Epidiolex Development
06/21/16 04:06 PMGW Pharmaceuticals Announces New Planned Epidiolex (Cannabidiol or CBD) Development Program in Infantile Spasms (IS)
06/21/16 08:00 AMBuy Insys Therapeutics Before Medical Marijuana Reaches A Tipping Point -
06/20/16 10:33 AMThis Weeks Broker Views For GW Pharmaceuticals Plc (GWPH) - Fiscal Standard
06/15/16 01:55 PMEconomics of Pot: The Problems With Investing in Marijuana -
06/15/16 01:55 PMEconomics of Pot: The Problems With Investing in Marijuana -
06/11/16 10:41 AMSay Hello to the 25th and Newest State to Legalize Medical Marijuana -
06/10/16 07:04 AMCantor Fitzgerald Initiates Coverage on GW Pharmaceuticals PLC- ADR to Buy - Trade Calls
06/09/16 04:22 AMGW Pharmaceuticals: Next Up, LGS
06/09/16 04:22 AMGW Pharmaceuticals Plc (NASDAQ:GWPH) Review on Earnings
06/06/16 09:49 PMAnalysts Rating: GW Pharmaceuticals plc (NASDAQ:GWPH), Shire PLC (ADR) (NASDAQ:SHPG), Weatherford ... - KC Register
06/06/16 07:54 AMAnalysts and Technical Report on GW Pharmaceuticals PLC (ADR) (NASDAQ:GWPH) - Street Report
06/05/16 04:19 PMAfter Last Week What Do Analysts Think Of GW Pharmaceuticals Plc (GWPH) - Share Trading News
06/05/16 04:19 PMAfter Last Week What Do Analysts Think Of GW Pharmaceuticals Plc (GWPH) - Share Trading News
06/04/16 04:20 PMGW Pharmaceuticals Plc (NASDAQ:GWPH): Stock Performance Recap - HNN
About GW Pharmaceuticals PLC-

GW Pharmaceuticals PLC- logoGW Pharmaceuticals plc is involved in the development of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant. The Company develops a portfolio of cannabinoid medicines, including Epidiolex, which is an oral medicine for the treatment of refractory childhood epilepsies. The Company operates through three segments: Commercial, Sativex Research and Development (Sativex R&D), and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex R&D segment seeks to maximize the potential of Sativex through the development of indications. The Sativex R&D segment focuses on the Phase III clinical development program of Sativex for use in the treatment of cancer pain. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using the Company's cannabinoid technology platform.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GWPH
  • CUSIP:
Key Metrics:
  • Previous Close: $91.57
  • 50 Day Moving Average: $86.91
  • 200 Day Moving Average: $69.60
  • P/E Ratio: N/A
  • P/E Growth: 0.50
  • Market Cap: $2.00B
  • Current Quarter EPS Consensus Estimate: $-4.23 EPS
Additional Links:
GW Pharmaceuticals PLC- (NASDAQ:GWPH) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha